社区队列中甲状旁腺切除术后高钙血症持续与复发的50年分析
该研究基于Olmsted县1965-2010年单中心回顾性队列,纳入345例因原发性甲状旁腺功能亢进接受手术的患者,评估术后高钙血症的持续与复发情况。结果显示9%患者存在持续性高钙血症,14%出现复发,但仅3%需治疗,多数为短暂且与继发因素相关,建议术后长期监测血钙。
要点
- 术后高钙血症持续率9%,复发率14%,高于既往报告。
- 复发中位时间12.2年,术后高钙血症37%可归因继发因素。
- 仅3%患者需治疗,多数高钙血症为短暂性。
核心结论
- 成功甲状旁腺切除术后复发性高钙血症发生率高于既往报告,但多数为短暂且仅少数需治疗,建议长期随访血钙。
研究设计与样本
- 单中心回顾性人群队列,来自Olmsted县(明尼苏达州),纳入1965-2010年因原发性甲状旁腺功能亢进接受手术的345例患者。
主要发现
- 345例患者中女性占75.7%,中位年龄58.4岁(IQR 17.6);68%无症状,最常见症状为肌肉骨骼不适(28.4%)和肾结石(25.6%)。
- 术前中位血清钙11 mg/dL(IQR 10.8-11.4),中位甲状旁腺激素90 pg/mL(IQR 61-169 pg/dL);38%行双侧颈部探查,79%行单腺体切除。
- 仅3%患者需治疗术后高钙血症;复发和死亡的中位时间分别为12.2年和16.7年。
关键数值与推荐
- 持续性高钙血症定义为术后仍存在高钙血症,发生率为9%;复发定义为术后血钙恢复正常后再次出现高钙血症,发生率为14%。
临床怎么用
- 对成功甲状旁腺切除术后患者应考虑长期监测血清钙,以识别持续或复发性高钙血症。
- 多数术后高钙血症为短暂且与继发因素(如药物)相关,仅少数需治疗,避免过度干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited long-term follow-up of patients undergoing parathyroidectomy. Recurrence is described as 4% to 10%. This study evaluated persistence and recurrence of hypercalcemia in primary hyperparathyroidism after parathyroidectomy. METHODS: Single-institution retrospective (1965-2010) population-based cohort from Olmsted County (MN) of patients undergoing surgery for primary hyperparathyroidism. Patients' demographic data, preoperative and postoperative laboratory values, clinical characteristics, surgical treatment, and follow-up were noted. RESULTS: A total of 345 patients were identified, 75.7% female, and median age 58.4 years [interquartile range (IQR): 17.6]. In all, 68% of patients were asymptomatic and the most common symptoms were musculoskeletal complaints (28.4%) and nephrolithiasis (25.6%). Preoperative median serum calcium was 11 mg/dL (IQR: 10.8-11.4 mg/dL), and median parathyroid hormone was 90 pg/mL (IQR: 61-169 pg/dL). Bilateral cervical exploration was performed in 38% and single gland resection in 79% of cases. Median postoperative serum calcium was 9.2 mg/dL (IQR: 5.5-11.3). Nine percent of patients presented persistence of hypercalcemia, and recurrence was found in 14% of patients. Highest postoperative median serum calcium was 10 mg/dL (IQR: 6-12.4), and median number of postoperative calcium measurements was 10 (IQR: 0-102). Postoperative hypercalcemia was identified in 37% of patient. Fifty-three percent were attributed to secondary causes, most commonly medications, 22%. Three percent of patients required treatment for postoperative hypercalcemia. Median time to recurrence and death were 12.2 and 16.7 years, respectively. CONCLUSION: Recurrent hypercalcemia after successful parathyroidectomy is higher than previously reported. Most cases are transient and often associated to other factors with only the minority requiring treatment. Long-term follow-up of serum calcium should be considered in patients after successful parathyroidectomy.
引用
- Szabo Yamashita T, Mirande M, Huang CT, et al. Persistence and Recurrence of Hypercalcemia After Parathyroidectomy Over 5 Decades (1965-2010) in a Community-based Cohort. Ann Surg. 2022. PMID: 36017920. doi:10.1097/SLA.0000000000005688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。